$Pacific Biosciences of California(PACB)$ bullish.
ARK Investment Management, led by Cathie Wood, has significantly increased its stake in Pacific Biosciences of California (PACB) in late 2025 and early 2026, signaling a strong, continued conviction in the genomics company despite its financial challenges.
Recent Purchases: Between late October 2025 and early January 2026, ARK made multiple purchases, including over 1 million shares in a single transaction (Oct 31, 2025), 333,000 shares (Dec 23, 2025), and 423,426 shares (Jan 1, 2026).
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- wigglyz·02-02 15:34Solid move by ARK! Bullish on PACB long-term. [看涨]LikeReport